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results

GFe3 mediates degradation of gephyrin
We generated GFE3 by fusing GFP-GPHN.FingR, an antibodylike protein based on the 10FNIII domain of fibronectin that binds gephyrin with high affinity 11 , with the RING domain of XIAP, an E3 ubiquitin ligase 12 ( Supplementary Fig. 1 ). To test whether GFE3 can mediate the elimination of endogenous gephyrin, we compared the expression of synaptic proteins from cultures of cortical neurons expressing GFE3 and cultures expressing control constructs. Neurons that expressed either GPHN.FingR only or a fusion of the RING domain with a FingR containing random residues within its target binding domains (RandE3) displayed puncta of both gephyrin and PSD-95, a protein found at excitatory postsynaptic sites, whereas neurons expressing GFE3 displayed PSD-95 puncta but no gephyrin puncta (Fig. 1a-c and Supplementary Fig. 1 ).
To investigate GFE3's mode of action, we coexpressed GFE3, GPHN.FingR or RandE3 in COS-7 cells with gephyrin-GFP. In the course of 24 h, GFE3 reduced exogenous gephyrin-GFP by ~80% compared with the controls. This reduction was dependent on proteasome function as shown by treatment with lactacystin (clasto-lactacystin β-lactone), a highly specific and irreversible proteasome inhibitor (Supplementary Fig. 1 ). We also coexpressed gephyrin-GFP in COS-7 cells with hemagglutinin (HA)-ubiquitin and either GFE3, GPHN.FingR or RandE3 in the presence of lactacystin and immunoprecipitated with an anti-gephyrin antibody. Anti-HA staining of the precipitates revealed a prominent high-molecular-weight band in the GFE3 lane that likely corresponded to polyubiquitinated gephyrin ( Supplementary Fig. 1 ). Thus, our results are consistent with GFE3 causing polyubiquitination of gephyrin followed by degradation of gephyrin in the proteasome.
Although neuronal activity can be modulated using a variety of techniques, there are currently few methods for controlling neuronal connectivity. We introduce a tool (GFe3) that mediates the fast, specific and reversible elimination of inhibitory synaptic inputs onto genetically determined neurons. GFe3 is a fusion between an e3 ligase, which mediates the ubiquitination and rapid degradation of proteins, and a recombinant, antibody-like protein (Fingr) that binds to gephyrin. expression of GFe3 leads to a strong and specific reduction of gephyrin in culture or in vivo and to a substantial decrease in phasic inhibition onto cells that express GFe3. By temporarily expressing GFe3 we showed that inhibitory synapses regrow following ablation. thus, we have created a simple, reversible method for modulating inhibitory synaptic input onto genetically determined cells.
We sought to create a method for eliminating inhibitory inputs onto neurons by ablating gephyrin, a postsynaptic protein that clusters type A γ-aminobutyric acid (GABA A ) and glycine receptors [1] [2] [3] . Traditional means for eliminating protein expression, such as gene deletion 4 or short interfering RNA (siRNA) 5 , work by means of cutting off protein supply, and thus become effective only as the protein degrades, which can take a week or longer 6, 7 . Furthermore, these methods are not easily reversible. Therefore, our approach uses an E3 ligase enzyme, which marks proteins for degradation by mediating the covalent attachment of ubiquitin polypeptides to lysine residues, causing the marked proteins to be transported to the proteasome and degraded 8 . E3 ligases can be engineered to have arbitrary specificity by fusing their ubiquitin transferase domains with proteins that bind to specific targets. For instance, fusion of an E3 ligase with a GFP nanobody degrades exogenously expressed GFP in vivo 9 . However, endogenous proteins have been targeted with genetically encoded molecules in only a few cases 10 .
We have generated a protein, GFE3, that mediates the fast and specific degradation of gephyrin, eliminating the inhibitory synaptic inputs to the neurons in which it is expressed. Gephyrin
To quantify the effect of expressing GFE3 in neurons, we compared uninfected (control) neuronal cultures to cultures infected with a lentivirus encoding either GFE3, GPHN.FingR or RandE3. Lentiviral infection led to efficient expression of GFE3 and a sharp reduction of endogenous gephyrin, whereas infection with RandE3 or GPHN.FingR, while equally efficient, did not affect gephyrin expression (Supplementary Fig. 2 ). GFE3-expressing cultures expressed 80% less gephyrin compared with neurons expressing GPHN.FingR ( Fig. 1d and Supplementary Fig. 3 ). Despite this effect on gephyrin expression, GFE3 had a negligible effect on expression levels of the GABA A receptor, PSD-95, AMPA receptor subunit GluA1, NMDA receptor subunit GluN2B or the gephyrin interactors collybistin II 13 and GABARAP 14 (Fig. 1d) . Indeed, expression levels of these proteins were not significantly different in cells expressing GFE3 as compared to the three types of control cells ( Supplementary Fig. 4) . Thus, expression of GFE3 leads to the efficient, specific reduction of endogenous gephyrin levels.
Because gephyrin clusters GABA A receptors, we examined the effect of GFE3 on the receptors' distribution. In control cells GABA A receptors were clustered and colocalized with gephyrin, whereas in neurons transfected with GFE3 GABA A receptors were diffusely distributed and gephyrin staining was not visible (Fig. 1e,f and Supplementary Fig. 4) . Thus, reducing endogenous gephyrin by expressing GFE3 appears to release GABA A receptors from postsynaptic clusters, allowing them to distribute through the dendrites, but this reduction does not substantially reduce their expression, an observation consistent with results obtained with siRNA against gephyrin 15 . Furthermore, although expression of GFE3 causes a large change in gephyrin expression levels, GFE3 expression is not associated with changes in either cell viability or overall proteasome activity (Supplementary Fig. 5 ).
GFe3 expression eliminates phasic inhibition
To examine the functional consequences of GFE3 expression, we transfected cultured hippocampal neurons with GFE3, GFP (control) or RandE3. We recorded from neurons with access resistance below 30 MΩ that varied by 20% or less using the whole-cell patch-clamp technique. GFE3-expressing cells exhibited miniature inhibitory postsynaptic currents (mIPSCs) with a roughly 65% decrease in frequency and 30% reduction in amplitude when compared to control cells or to cells expressing RandE3 ( Fig. 2a-d expressing GFE3 showed no significant difference in either frequency or amplitude when compared with control cells (P > 0.75, Mann-Whitney; Supplementary  Fig. 6 ). To test whether functional GABA A receptors were still present on the neuronal membrane in cells expressing GFE3, we applied a high concentration of GABA (1 mM) to the bath. Under these conditions the amplitude of evoked currents was not significantly different between cells expressing GFE3 and controls (P > 0.5, Mann-Whitney; Fig. 2e,f) . This suggests that unclustered GABA A receptors are on the cell surface and remain functional. Furthermore, noise analysis of these data is consistent with the kinetics of GABA A receptors being similar in the two conditions (Supplementary Fig. 7 ).
To test the efficiency of GFE3 in abolishing GABAergic synaptic transmission in the intact brain, we virally infected indirect spiny projection neurons (iSPNs) to induce GFE3 or GPHN. FingR expression in a Cre-dependent manner in the dorsal striatum of Adora2A-cre mice, while simultaneously expressing channelrhodopsin2 (ChR2) in non-Cre-expressing striatal cells (Fig. 3a) . This approach resulted in light-evoked synaptic GABAergic transmission onto iSPNs, with GABA being released presumably mostly from direct SPNs, with some contribution from GABAergic interneurons 16 . A single light pulse reliably evoked GABA A -receptor-mediated synaptic currents under control conditions where we expressed GPHN.FingR, but currents were abolished in iSPNs expressing GFE3 (Fig. 3b) . We also found that spontaneous IPSCs were significantly reduced in both frequency (P = 0.0008, Mann-Whitney) and amplitude (P < 0.03, Mann-Whitney) in iSPNs expressing GFE3 compared with those expressing GPHN.FingR (Fig. 3c) . This reduction in spontaneous synaptic activity was selective for GABAergic transmission, as spontaneous excitatory inputs were unchanged (Fig. 3c) . Thus, expression of GFE3 specifically eliminates functional GABAergic synapses without affecting glutamatergic synapses. In contrast, the amplitude of tonic GABA currents [17] [18] [19] showed a tendency toward reduction, but this change did not rise to the level of significance (Fig. 3d,e) . These results indicate that while there might be a partial reduction in total (synaptic and extrasynaptic) GABA A receptor expression at the cell surface, elimination of GABA A receptors from the synapse by GFE3 is not due to a general elimination of GABA A receptors from the cell, consistent with our results in dissociated cultures (Fig. 1e,f and 2e,f) . Thus, our results are consistent with GFE3 specifically eliminating the phasic inhibitory input onto neurons in the intact brain.
GFe3 in zebrafish spinal neurons causes motor defects
To further test the efficacy of GFE3 in vivo, we injected zebrafish zygotes with a plasmid containing GFE3-GFP driven by the mnx1 enhancer, which restricts expression to spinal cord neurons 20 . Expression of GFE3-GFP was both efficient and specific as indicated by numerous labeled cells along the midline in the spinal cord 2 d post injection (Fig. 4a) . In fish expressing RandE3-GFP, (b) Evoked synaptic currents in control and GFE3-expressing iSPNs in control conditions (black) and after slices were exposed to SR95331 (10 µM), a GABA A receptor antagonist (red). (c) Spontaneous inhibitory currents (sIPSCs, top) were reduced by GFE3 compared with control in both frequency (P < 0.0008, Mann-Whitney) and amplitude (P < 0.03, Mann-Whitney), but no effect was observed on the frequency (P > 0.9, Mann-Whitney) or amplitude (P > 0.17, Mann-Whitney) of excitatory currents (spontaneous EPSCs (sEPSCs), bottom). Representative example traces are shown on the left, and quantification summaries are shown on the right. (d) Tonic GABA A receptor current was quantified as the change in baseline holding current following application of SR95331 (10 µM). (e) Expression of GFE3 resulted in a tendency to reduction of tonic GABA A receptor current, (P = 0.12, Mann-Whitney). For all experiments, gray circles indicate individual cells from a total of four animals (inhibitory inputs) or two animals (excitatory inputs); bars indicate mean ± s.e.m.
GFP was visible within the cell bodies of spinal cord neurons, while at the outer edge of these cell bodies there was a ring of gephyrin staining (Fig. 4b) . In contrast, gephyrin staining was sharply reduced in the cell bodies of spinal cord neurons expressing GFE3-GFP (Fig. 4c) . Discontinuous staining on the edge of the GFP staining likely arose from unlabeled neighboring cells. Furthermore, the average level of gephyrin staining surrounding the cell bodies of cells expressing GFE3-GFP was significantly lower than that of cells expressing RandE3-GFP alone (P < 0.008, Mann-Whitney; Fig. 4d) .
A major role of inhibitory neurons in the zebrafish spinal cord is to prevent cocontractions of opposing muscles by inhibiting contralateral motoneurons 21 . Accordingly, zebrafish expressing mutant glycine receptors in the spinal cord that fail to cluster at inhibitory synapses exhibit cocontraction of opposing muscles within the tail 22, 23 . Zebrafish expressing GFE3-GFP (Supplementary Videos 1 and 2) exhibited a lack of coordination when compared to zebrafish expressing RandE3-GFP (Supplementary Videos 3 and 4), which would be expected if the lack of gephyrin caused cocontraction of opposing muscles. To quantify these effects we took advantage of a peculiarity of the stereotyped tail-flick behavior 24, 25 . Fish expressing RandE3-GFP bent their tails in a tight circle so that the tip of the tail touched the base of the tail ( Fig. 4e and Supplementary Fig. 8) , where it connects with the abdomen of the fish. In contrast, fish that expressed GFE3-GFP did not touch the bases of their tails with the tips (Fig. 4f and Supplementary Fig. 8) . Indeed, the minimum distance between the base and the tip of the tail during five tail flicks in zebrafish expressing GFE3-GFP was more than twice that of the same distance measured in zebrafish expressing RandE3-GFP (Fig. 4g) . These results are consistent with expression of GFE3 causing the efficient ablation of gephyrin in vivo, resulting in the loss of phasic inhibition within spinal cord neurons in zebrafish.
GFe3-mediated loss of gephyrin is reversible
An advantage of the GFE3 approach is that gephyrin expression is modified at the level of protein degradation, and thus the level of gephyrin is expected to respond quickly to the expression or elimination of GFE3. To test this hypothesis, we expressed GPHN.FingR-GFP along with doxycycline (dox)-dependent GFE3-TagRFP in cortical neurons in culture and incubated for 4-7 d without dox, labeling inhibitory synapses with GPHN. FingR-GFP. We then induced expression of GFE3-TagRFP using dox ( Fig. 5a and Supplementary Fig. 9 ) and found efficient elimination of gephyrin in less than 5 h as indicated by the absence of GPHN.FingR-GFP labeling (Fig. 5a,b) . Fixing the same cells and immunostaining for endogenous gephyrin (green) and GFE3-TagRFP (red) confirmed that endogenous gephyrin had been eliminated (Fig. 5c) . In contrast, transfection of siRNA led to an 80% reduction in the number of gephyrin puncta after 5 d in dissociated hippocampal cultures 26 .
To demonstrate reversible elimination of gephyrin expression, we added dox to neurons transfected with GPHN.FingR-GFP and dox-dependent GFE3-TagRFP for 24 h, and then we removed dox and waited 48 h to determine whether the gephyrin puncta would return (Supplementary Fig. 9 ). As in the previous experiment, gephyrin puncta labeled with GPHN.FingR-GFP disappeared following 24 h of dox-induced GFE3-TagRFP expression (Fig. 5d,e and Supplementary Fig. 9 ). Removal of dox for 48 h resulted in a reappearance of gephyrin puncta (Fig. 5f) , and many of these puncta reappeared in places that were close to their original locations (Fig. 5g) . Gephyrin immunostaining at 48 h after removal of dox showed that newly formed gephyrin puncta colocalized with staining for presynaptic glutamic acid decarboxylase (GAD)-65 (Fig. 5h) , suggesting that the recovered gephyrin puncta have corresponding presynaptic sites and thus are likely part of reconstituted synapses. Finally, quantitation of GPHN.FingR-GFP showed that, following recovery, total FingR staining in puncta is present at levels that are comparable to initial levels (Fig. 5i) . Thus, by controlling the expression of GFE3 it is possible to induce the reversible ablation of gephyrin. discussion FingRs can target fluorescent proteins to endogenous target proteins, allowing the targets and the macromolecular structures where they reside to be visualized in vivo 11, 27 . Here we show that an E3 ligase can also be targeted specifically using a FingR, causing expression of its target protein to be quickly and reversibly eliminated. Although this is not the first method developed for direct elimination of protein expression, it differs in important respects from previously described methods. Many of these methods are specific to exogenously expressed proteins 9,28 , or they are not genetically encoded 29 . Furthermore, FingRs bind to their targets without affecting target function or expression 11 , which means that protein elimination is entirely due to increased degradation through the E3 ligase and the ubiquitin proteasome system. This is distinct from single-chain variable fragment (scFv)-based proteins that reduce gephyrin expression through an unknown mechanism, with unknown off-target effects 30 . In addition, because the gephyrin FingR was specifically engineered to bind gephyrin with very high affinity and specificity, the fidelity with which it degrades its target is likely to be much higher than that of a system that depends on naturally occurring protein-protein interactions, such as those involving PDZ domains, which have relatively low affinity and specificity 31, 32 . Furthermore, positively charged cellpermeant peptides such as Tat, upon which systems mediating degradation with peptides rely, are inefficient and unstable, and they induce cytotoxicity 33 .
E3 ligases can be fused to FingRs targeted against other proteins, suggesting that our approach could be generalizable for reversibly ablating a wide range of endogenous targets. In addition, because of its modular nature, we envision that GFE3 function could be engineered to rely on light-dependent association of its two domains, making the complex active in response to light.
Modulating the excitability of neurons using optogenetics has revealed the electrophysiological properties of specific neuronal cell types and their roles in circuits and functional networks, which was not possible with previous pharmacological approaches. Like optogenetic proteins, GFE3 can be expressed in specific cell types. However, it acts at a qualitatively different level than optogenetics, modifying endogenous synaptic connectivity rather than directly inducing the opening of exogenous ion channels or the activation of pumps 34 . GFE3 also differs from AS-PaRac1, which can inducibly reduce the strength of excitatory synapses, in that GFE3 eliminates gephyrin, a component of the synapse, whereas AS-PaRac1 causes changes in the actin cytoskeleton supporting dendritic spines by modulating the function of the G protein Rac1 (ref. 35) .
Targeting expression of GFE3 to excitatory cells should increase excitability within a specific brain region, whereas expressing GFE3 in inhibitory cells should decrease excitability. Thus, it should be possible to probe the effects of systematically modulating the excitability of specific regions of the brain, both in wildtype animals and in disease models, in a way that does not directly interfere with the firing patterns of cells.
In conclusion, GFE3 provides a fast, specific and reversible method for modulating inhibition onto defined cells. Furthermore, it provides a framework for generating a diverse array of genetically encoded modulators of expression and function that act specifically on virtually any target protein. online methods cDNA constructs. The gephyrin (GFE3) and random (RandE3) ablating FingRs were constructed by fusing a DNA sequence encoding three consecutive hemagglutinin (HA) tags followed by the amino acids 440-496 of the RING domain of rat XIAP 3′ to the gephyrin FingR gene 11 or to the random FingR gene FN04 (ref. 36) (Supplementary Fig. 1 ). In addition, the gene for EGFP or TagRFP (Evrogen, cat. # FP141) was linked 3′ to a DNA spacer encoding the amino acid sequence GGGS repeated four times, which was then fused 5′ to the gephyrin FingR to allow for direct visualization of the GFE3 in living cells. Expression constructs were made by ligating these genes into the pCAG, pFUW or pAAV (ref. 37) expression vectors. The construction of transcriptionally controlled GPHN.FingR-GFP-CCR5ZFL-KRAB(A) (Addgene, cat. # 46296) and gephyrin-GFP were described previously 11 . Note that in COS-7 cell experiments and in experiments where cells were transduced with lentivirus a nontranscriptionally controlled version of GPHN.FingR was used, but transcriptionally controlled GPHN.FingR was used in all other contexts. HA-tagged human ubiquitin was inserted into the constitutive mammalian expression vector pcDNA3 (Addgene plasmid # 18712) 38 . Plasmids for expression of RandE3 or GFE3 in zebrafish were created by ligating the assembled gene (RandE3 or GFE3) into the modified expression vector pMT (3mnx1), which contains a triplicated enhancer element from the mnx1 gene upstream of the multiple cloning site (MCS) that drives expression of the ablating FingR in spinal cord neurons 20 . A vector to mediate inducible expression of GFE3 (GFE3-TagRFP ind ) was generated by subcloning TagRFP-4(GGGS)-GFE3 into the pTRE-3G vector (Tet-On 3G, Clontech, cat. # 631337). GFE3, RandE3, or GPHN. FingR were inserted into the MCS of the pFUW vector for production of lentivirus at the USC School of Pharmacy Lentiviral Laboratory. Similarly, GFE3 or GPHN.FingR were subcloned into the 'cre-on' pAAV-EF1a-DIO vector for production of AAV at the University of Pennsylvania School of Medicine Vector Core. The sequences for all constructs were verified by DNA sequencing. Sequence information is provided as Supplementary Data 1. Ubiquitination and proteasome dependency. COS-7 cells (ATCC, cat. # CRL-1651) were cultured in Dulbecco's modified eagle's medium (ATCC, cat. # 30-2002) supplemented with 10% FBS in 5% CO 2 to a confluency of 80% on a 100 × 20 mm tissue culture dish before being cotransfected with constructs constitutively expressing the RandE3, GFE3 or GPHN.FingR along with gephyrin-GFP and HA-ubiquitin. 24 h after transfection, cells were lysed in 1 mL of lysis buffer (150 mM NaCl, 1 mM EDTA, 10 mM Tris, pH 8.0, 1% NP40, 0.12 mg/mL PMSF, 2 µg/mL leupeptin, 1 µg/mL aprotinin, 10 mM NaF and 1 µg/mL pepstatin). Proteasome activity in cells was arrested by adding the highly specific and irreversible inhibitor clasto-lactacystin β-lactone (10 µM, VWR, cat. # 80052-808) in DMSO to the culture medium. To examine gephyrin ubiquitination in cells, 500 µL of lysate was precleared with agarose beads for 2 h at 4 °C and then incubated overnight at 4 °C with a rabbit anti-gephyrin antibody (Bethyl Laboratories, cat. # A304-245A) diluted 1:100. The next day, 50 µL of protein A/G agarose beads (Pierce, cat. # 20421) were added to the lysate. The beads were then nutated at 4 °C for 8 h to immunoprecipitate (IP) gephyrin, washed six times in wash buffer (as lysis buffer, except with 0.1% NP40) and finally boiled for 5 min in Laemmli sample buffer (62.5 mM Tris-HCl, pH 6.8, 2.5% SDS, 10% glycerol, 0.02% bromophenol blue and 5% 2-mercaptoethanol). Cell lysate and eluate from the gephyrin IP were run on precast Any kD SDS-PAGE gels (Bio-Rad, cat. # 4569033) and transferred to a low-fluorescence PVDF membrane (Bio-Rad, cat. # 1620264). The blots were then probed with a mouse anti-gephyrin antibody (Synaptic Systems, cat. # 147 111), 1:1,000, a mouse anti-β-tubulin antibody (Sigma, cat. # T4026), 1:5,000, or a mouse anti-HA antibody (Covance/BioLegend, cat. # 901513), 1:500. Secondary antibody used was goat anti-mouse Alexa Fluor 750 (Thermo Fisher Scientific, cat. # A-21037), 1:1,000. Blots were imaged with the Odyssey Infrared Imaging System (LI-COR Biosciences). Steady-state protein levels were determined using ImageJ software (US National Institutes of Health). Prior to analyses of data, gephyrin-GFP levels were normalized to β-tubulin levels. Data are represented as mean ± s.e.m. and were compared using the nonparametric Kruskal-Wallis test. A P value < 0.05 was considered significant. The supplier (ATCC) tested the cells for mycoplasma and confirmed their species of origin by COI assay.
Expression of gephyrin-ablating
Lentiviral transduction efficiency.
Efficiency of lentiviral transduction with GFE3, RandE3 or GPHN.FingR was assessed by counting the number of GFP-positive and GFP-negative cells in five 133.3 µm 2 images taken from infected Delta T dishes. In brief, live-cell morphology and GFP expression were imaged and analyzed first with bright-field illumination and fluorescein isothiocyanate (FITC) fluorescence. Cells were then fixed and stained for GFP and gephyrin and mounted in Fluoromount-G with DAPI (Electron Microscopy Sciences, cat. # 17984-24).
npg
A GFP-positive cell was identified by colocalization of GFP with DAPI in the cell body, whereas a GFP-negative cell had no colocalization of DAPI with GFP. Image analyses were done blinded with ImageJ software. Data are represented as mean ± s.e.m. and were subjected to a Kruskal-Wallis test. A P value < 0.05 was considered significant.
Quantitation of knockdown of synaptic protein levels following expression of GFE3. Dissociated rat cortical neurons seeded at a density of 7.5 × 10 5 on 100 × 20 mm tissue culture dishes were transduced with 3.0 × 10 6 IFUs of lentivirus with the RandE3, GFE3 or GPHN.FingR. After 16 h of expression, cells were lysed in 1 mL of lysis buffer with 1% Triton X-100. Samples were then run on Any kD SDS-PAGE gels and transferred to PVDF membrane. The blots were probed with a mouse anti-gephyrin antibody, 1:1,000, a rabbit anti-GABA A receptor α1 antibody (EMD Millipore, cat. # 06-868), 1:1,000, a mouse anti-PSD-95 antibody (NeuroMab, cat. # 75-028), 1:1,000, a mouse anti-GluA1 antibody (NeuroMab, cat. # 75-327), 1:1,000, a mouse antiGluN2B antibody (NeuroMab, cat. # 75-097), 1:1,000, a mouse anti-collybistin II antibody (Santa Cruz Biotechnology, cat. # sc-136393), 1:1,000, a rabbit anti-GABARAP antibody (Origene, cat. # TA307845), 1:1,000, or a mouse anti-β-tubulin antibody, 1:5,000. Secondary antibody used was goat anti-mouse Alexa Fluor 750, 1:1,000, or goat anti-rabbit Alexa Fluor 750, 1:1,000 (Thermo Fisher Scientific, cat. # A-21039). The blots were imaged at multiple intensities using the Odyssey Infrared Imaging System. Measurements of synaptic protein steady-state levels from four independent experiments were obtained using ImageJ software. This data was normalized to β-tubulin levels and subjected to a Kruskal-Wallis test. All data are expressed as mean ± s.e.m. A P value < 0.05 was considered significant. Image capture and analysis of cortical neurons. Imaging of fixed, immunostained cells was done on a Bio-Rad MRC-1024 confocal microscope. Each cell was imaged as a single optical section with either a ×20 objective at 1.0× zoom or an ×40 objective at 2.0× zoom, unless otherwise noted. Stained levels of gephyrin, PSD-95 and GABA A R were determined by measuring mean pixel intensity on dendrites from neurons with similar morphology that expressed GFE3, RandE3 or GPHN.FingR. Image analyses were performed blinded with ImageJ software. Data are represented as mean ± s.e.m. and were compared using a Kruskal-Wallis or Mann-Whitney test. A P value < 0.05 was considered significant. Living cells on Delta T culture dishes were imaged in HBSS buffer, supplemented with 10 mM HEPES and prewarmed to 37 °C, with a ×20 air objective or ×60 water objective at 1.0× zoom on an Olympus IX81 inverted microscope equipped with the Delta T system (Bioptechs, cat. # 0420-4), an EM-CCD digital camera (Hamamatsu, cat. # C9100-02), DAPI, GFP-mCherry and Cy5.5 filter cubes (Chroma Technology, cat. # 49000, cat. # 59022 and # SP105), an MS-2000 XYZ automated stage (Applied Scientific Instrumentation), an X-cite exacte mercury lamp (Excelitas Technologies) and Metamorph software (Molecular Devices). Imaging of GFP and TagRFP was done at 25% intensity with a 400 ms exposure to minimize bleaching and phototoxicity affects. Intensity values of puncta labeled by transcriptionally controlled GPHN.FingR-GFP in images taken at different time points were determined with ImageJ software. All analyses of cells were performed blinded. Only neurons with healthy morphology were selected for quantification, and none of the images used contained saturated pixels in the axon or dendrites of cells. Data are npg Before behavior experiments (i.e., spontaneous tail flick), 17-22 h postfertilization zebrafish embryos in egg water were carefully dechorionated with a pair of #5 forceps (Fine Science Tools). 200 µL of egg water supplemented with 0.003% 1-phenyl 2-thiourea (PTU, Sigma-Aldrich, cat. # P7629)-to inhibit pigment formation-was added to individual wells of a 96-well plate, and individual zebrafish were placed into each of the filled wells with a glass pipette. Gender could not be determined due to the age of the fish 44 . Zebrafish tail-flicking behavior was recorded (40 frames per second) from below the well plate using a compact USB 3.0 CMOS camera (Cat. # DCC1545M, Thorlabs). After tailflick imaging, zebrafish were kept overnight at 28 °C within the 96-well plate. At 2 dpf, zebrafish injected with the spinal cord neuron expressing GFE construct were anesthetized with 0.015-0.03% MS-222 (Argent Laboratories), embedded in 1-1.5% SeaPlaque agarose within a 30× Danieau's solution (17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO 4 , 0.18 mM Ca(NO 3 ) 2 and 1.5 mM HEPES) and imaged using a Plan Apochromat ×20 objective on a commercial LSM 700 confocal microscope (Carl Zeiss AG), as similarly described 45 . Mosaic-labeled GFP-positive cells were visualized throughout the zebrafish spinal cord using the tiled confocal stack feature of the microscope. For immunostaining of zebrafish, 1-2 dpf zebrafish were anesthetized in 0.03% MS-222 and were fixed in 2% Trichoroacetic acid for 3 h at room temperature. After 5 washes in PBS pH 7.4 with 0.5% Triton X-100 (PBT), fish were blocked overnight in blocking buffer (PBS pH 7.4, 1% bovine serum albumin, 1% DMSO, 0.1% Triton X-100 and 2% normal goat serum) at 4 °C on an orbital shaker. Mouse anti-gephyrin antibody (Synaptic Systems, cat. # 147 111) was applied at a 1:250 dilution in blocking buffer and the zebrafish were left at 4 °C on an orbital shaker for 72-96 h. After 5 washes in PBT, goat antimouse Alexa Fluor 594 antibody (Thermo Fisher Scientific, cat. #A-11005) was applied at a 1:2,000 dilution in blocking buffer, and the sample was left on an orbital shaker at 4 °C for 14-18 h. Following 5 washes in PBT, samples were washed in PBS pH 7.4. For clearing, samples were progressively dehydrated in glycerol, ultimately ending in a solution of 75% glycerol / 25% PBS pH 7.4. Samples were placed on #1.5 coverslips and were imaged with a commercial LSM 780 confocal microscope (Carl Zeiss AG) using an ×63 water objective. Analyses of gephyrin levels in confocal images were performed blinded with ImageJ software. All data are expressed as mean ± s.e.m. Zebrafish were included in analysis that had at least 20 labeled motoneurons. No randomization was used.
Stereotaxic intracranial injections.
To examine inhibitory synaptic inputs, a total of 1 µl AAV-DIO-GFE3-GFP ('cre-on') mixed at a 2:1 ratio with AAV-FAS-ChR2-mCherry ('cre-off ' 37 ) was delivered by intracranial injection into the striatum of Adora2a-cre mice (GENSAT: B6.FVB(Cg)-Tg(Adora2acre)KG139Gsat/Mmucd) (P18-P22) of both sexes maintained under deep isoflurane anesthesia. The nonablating gephyrin intrabody (AAV-DIO-GPHN.FingR-GFP 11 ) was used as an internal control in the other hemisphere of each mouse. Note that AAV-EF1a-DIO-GFE3 and AAV-EF1a-DIO-GPHN.FingR are AAV serotype 9, AAV-EF1a-FAS-ChR2-mCherry is serotype 8 and 3.8 × 10 10 genome copies (GC) at a titer of 3.8 × 10 13 GC/mL were used. To test excitatory inputs, AAV-DIO-GFE3-GFP or AAV-DIO-GPHN.FingR-GFP mixed with AAV-hSyn-cre at a 100:1 GC ratio was injected into the striatum of age-matched wildtype mice of both sexes (C57Bl/6, Charles River). Injection coordinates were 0.7 mm anterior from bregma, 1.8 mm lateral, and 2.45 mm below pia, and expression time was at 12-14 d.
Slice preparation and electrophysiology. Acute sagittal brain slices were prepared, and electrophysiological recordings obtained, as described before 46 , with the following variations: spiny projection neurons of the indirect pathway were identified by GFP expression and their electrical properties and synaptic currents were recorded using a high-chloride pipette solution containing (in mM) 125 CsCl, 10 TEA-Cl, 0.1 EGTA (CsOH), 10 HEPES, 3.3 QX-314 (Cl − ), 1.8 MgCl 2 , 4 Na 2 -ATP, 0.3 Na-GTP, 8 Na 2 -phosphocreatine (pH 7.3 adjusted with CsOH; 295 mOsm kg −1 ). GABA A -receptor-mediated currents were recorded as inward currents in voltage-clamp mode at V hold = −70 mV in the presence of the AMPA-and NMDA-type glutamate receptor inhibitors NBQX and (R)-CPP (10 µm each). Excitatory currents were isolated by adding SR95331 (10 µM) to the bath solution. Tonic GABA A -receptor-mediated currents were defined as the difference in holding current before and after bath application of SR95331 (10 µM). Pipette resistance was 2.5-3 MΩ, and all recordings were performed at 33-34 °C. Errors due to the voltage drop across the series resistance (<15 MΩ) were left uncompensated. ChR2 was activated by a single 1 ms pulse of light delivered by a 473 nm laser using full-field illumination through the objective (~3 mW mm −2 ) at 30 s intervals. All pharmacological reagents were obtained from Tocris.
Data acquisition and analysis. Membrane currents were acquired as described previously 46 and analyzed in Igor Pro (Wavemetrics). For display and analysis of optically evoked synaptic membrane currents, ten consecutive traces were averaged for each cell. Data are represented as mean ± s.e.m. (bars) overlaid over individual data points (gray circles) and were compared using the nonparametric Mann-Whitney test. P values are reported directly, and values smaller than 0.05 were considered statistically significant.
Statistics.
No statistical methods were used to predetermine sample size. Nonparametric tests were used throughout, as the data are not normally distributed. Data are represented as mean ± s.e.m. Statistical comparisons are between groups with similar variances.
